Atara Biotherapeutics, Inc.

JANE STREET GROUP, LLC ATRA

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/16/2024

Shares

62,651

Value ($000)

43

Weight

0.0%

2019 Q4 - 2024 Q1 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/16/2024	43	0.0%	62,651	3/31/2024
2023 Q4	2/15/2024	68	0.0%	132,177	12/31/2023
2023 Q3	11/15/2023	35	0.0%	23,404	9/30/2023
2023 Q2	8/14/2023	711	0.0%	441,771	6/30/2023
2023 Q1	5/16/2023	53	0.0%	18,257	3/31/2023
2022 Q4	2/15/2023	485	0.0%	148,007	12/31/2022
2022 Q3	11/15/2022	295	0.0%	77,914	9/30/2022
2022 Q2	8/16/2022	195	0.0%	25,146	6/30/2022
2021 Q4	2/15/2022	208	0.0%	13,172	12/31/2021
2021 Q3	11/16/2021	424	0.0%	23,674	9/30/2021
2021 Q2	8/16/2021	229	0.0%	14,780	6/30/2021
2021 Q1	5/18/2021	314	0.0%	21,895	3/31/2021
2020 Q4	2/17/2021	598	0.0%	30,478	12/31/2020
2020 Q3	11/17/2020	1,401	0.0%	108,129	9/30/2020
2020 Q2	8/17/2020	248	0.0%	17,014	6/30/2020
2019 Q4	2/14/2020	936	0.0%	56,835	12/31/2019